Cover Image
市場調查報告書

脊椎固定:全球市場分析語預測

MediPoint: Spinal Fusion - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 305463
出版日期 內容資訊 英文 170 Pages
訂單完成後即時交付
價格
Back to Top
脊椎固定:全球市場分析語預測 MediPoint: Spinal Fusion - Global Analysis and Market Forecasts
出版日期: 2014年06月09日 內容資訊: 英文 170 Pages
簡介

脊椎固定手術自1990年初期實施以來,已發展十分成熟。不但在美國是最為頻繁實施的手術之一,也是同領域中最大的市場。全球隨著高齡化的發展,脊椎病變的發生率也逐漸上升,可預測脊椎固定市場的未來將穩定的成長。

本報告彙整了脊椎固定術的概要以及地區動態,未被滿足的需求與市場機會分析、市場成長因素的障礙、及其參與企業的市佔率與檔案等內容。

第1章 目次

第2章 前言

第3章 業界概要

  • 適用
  • 裝置種類
    • 脊椎板固系統
    • 身體護架
    • 脊椎骨釘
  • 施術動向
    • 美國
    • 歐洲五國
    • 南美
    • 亞派地區
  • 市場切入點
    • 政府法規
    • 導入
    • 報帳趨勢

第4章 市場動向:合併、收購、主要合作

  • 概要
    • Amedica Corporation收購US Spine
    • Alphatec Spine收購Scient'x Group
    • Biomet收購Lanx, Inc.
    • Globus Medical收購Facet Solutions
    • Integra LifeSciences Holdings Corporation收購SeaSpine, Inc.
    • Medtronic收購Advanced Medical Technologies與中國的Kanghui
    • Nuvasive收購ANC
    • TranS1 Inc.收購Baxano Inc.
  • 經濟影響

第5章 未被滿足需求

  • 低侵入性手術的償還對像擴大
  • 決定固定性能的方法不足
  • 長期固定所使用的技術進步
  • 幫助固定的材料研究開發
  • 改善骨頭與螺絲之間的骨融合

第6章 市場的機會分析

  • 低侵入性技術指標的構築
  • 藉由獎學金計畫擴大低侵入性手術訓練機會
  • 增加醫療儀器植入物與生物製劑的合作
  • 即時固定術的裝置開發
  • 配合脊椎植入物患者的客製化

第7章 市場促進因子

  • 高齡化
  • 增加在腰椎管狹窄方面的應用
  • 治療脊椎不穩定與退化性疾病的黃金標準
  • 各種應用治療
  • 對低侵入性技術的偏好
  • 導航技術的進步

第8章 市場的障礙

  • 鄰腰椎鄰近節病變的發生機率
  • 非固定技術的表現
  • 在美國,對於脊椎固定數的審查增加
  • 私人付款者的限制報帳
  • 軸向背痛的表現

第9章 產品線評估

第10章 試驗分析

第11章 現在與未來的參與企業

  • 概要
  • 企業策略動向
  • 企業檔案
    • Aesculap
    • Alphatec Spine
    • Amedica Corporation
    • Medtronic Spinal and Biologics
    • DePuy Spine
    • Globus Medical
    • K2M
    • Biomet
    • Stryker
    • Zimmer
    • Nuvasive
    • Orthofix
    • Integra LifeSciences

第12章 市場見解

  • 企業的市佔率
  • 分類別
  • 地區別

第13章 附錄

圖表

目錄
Product Code: GDME0190MAR

Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period.

However, there are still several barriers that are dampening the intervention's potential adoption levels. Most notably, in the US, public payers are beginning to implement strict measures on reimbursement documentation in an effort to eliminate medically unnecessary procedures. For example, Medicare will now require spine surgeons to document conservative efforts to alleviate the patient's symptoms prior to undergoing surgery. Another market barrier is the emergence of a new class of medical device technologies that seek to capitalize on one of the persistent weaknesses of spinal fusions. Non-fusion technologies are designed to retain motion at the operated level and reduce stresses experienced by adjacent segments. This is meant to eliminate the progression of symptomatic adjacent segment disease, which still troubles spinal fusion's effectiveness to this day.

The spinal fusion market encompasses a variety of implantable medical technologies, where multiple devices can be utilized in a single procedure. For this research report, the three leading device categories are covered: spinal plating systems, interbody cages, and pedicle screw systems. Additionally, the specific anatomical regions being operated on are covered, including the cervical and thoracolumbar regions. Furthermore, this report analyzes the adoption of these implantables in one level, two level, and three level surgeries, creating the most comprehensive and accurate market valuations and coverage. The report analyzes how these surgical trends vary globally in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India).

Highlights

Key Questions Answered

  • The reimbursement landscape for spinal fusion procedures in the US is dramatically changing by requiring spine surgeons to provide proof of medical necessity. (Q).How will this payer pressure affect the increasing number of spinal fusion procedures in the US?
  • One of the drivers for the spinal fusion market is the vast number of indications in which the surgery can be used. (Q).Which indications for spinal fusion have seen the highest adoption rates in the past five years? (Q).Which indications will have high adoption rates in the next five years?
  • Non-fusion medical devices were developed to eliminate the progression of symptomatic adjacent segment disease, a major problem still associated with spinal fusion surgeries. (Q).Which non-fusion technologies pose the largest threat to spinal fusion procedures?
  • The research and development (R&D) efforts amongst orthopedic medical device manufacturers are intense. (Q).What are the trends in the pipeline products for spinal fusion procedures that will have the most impact on the competitive landscape? (Q).Which companies are expected to become key players?
  • Similar to other medical device markets, emerging economies will be a source of immense growth for the spinal fusion market. However, certain established economies will have large Compound Annual Growth Rates (CAGRs) as well. (Q).Which emerging economies will experience the largest CAGRs over the forecast period? (Q).Which established economies will experience the largest CAGRs over the forecast period?

Reasons to buy

  • "What Do Physicians Think?" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision-makers in every organization, allowing them to act on high-quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Overview
  • 2.2. Catalyst

3. Industry Overview

  • 3.1. Indications
  • 3.2. Types of Devices
    • 3.2.1. Spinal Plating Systems
    • 3.2.2. Interbody Cages
    • 3.2.3. Pedicle Screw Systems
  • 3.3. Procedure Trends
    • 3.3.1. US
    • 3.3.2. 5EU
    • 3.3.3. South America
    • 3.3.4. APAC
  • 3.4. Market Access
    • 3.4.1. Regulation
    • 3.4.2. Adoption
    • 3.4.3. Reimbursement Trends

4. Market Dynamics: Mergers, Acquisitions and Key Partnerships

  • 4.1. Overview
    • 4.1.1. Amedica Corporation Acquires US Spine
    • 4.1.2. Alphatec Spine Acquires Scient'x Group
    • 4.1.3. Biomet Acquires Lanx, Inc.
    • 4.1.4. Globus Medical Acquires Facet Solutions
    • 4.1.5. Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc.
    • 4.1.6. Medtronic Acquires Advanced Medical Technologies and China's Kanghui
    • 4.1.7. Nuvasive Acquires ANC
    • 4.1.8. TranS1 Inc. Acquires Baxano Inc.
  • 4.2. Economic Impact

5. Unmet Needs

  • 5.1. Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures
  • 5.2. Lack of Definitive Methods to Determine Fusion Performance
  • 5.3. Technological Developments in the Use of Long Fusions
  • 5.4. Research and Development into Fusion Enhancers
  • 5.5. Improve Osseointegration of Bone and Screw Interface

6. Market Opportunity Analysis

  • 6.1. Develop Signature Minimally Invasive Technique
  • 6.2. Market Minimally Invasive Training Opportunities to Fellowship Programs
  • 6.3. Increased Collaboration of Medical Device Implants and Biologics
  • 6.4. Develop a Device that Provides Real-Time Fusion Updates
  • 6.5. Increased Customization of Spinal Implants to Patient Anatomy

7. Market Drivers

  • 7.1. Aging Patient Populations
  • 7.2. Growth in the Spinal Stenosis Indication
  • 7.3. Gold Standard for Treating Spinal Instability and Degenerative Conditions
  • 7.4. Treatment for a Variety of Indications
  • 7.5. Preference for Minimally Invasive Techniques
  • 7.6. Advances in Navigation Technology

8. Market Barriers

  • 8.1. Incidence of Adjacent Segment Disease
  • 8.2. Performance of Non-Fusion Technologies
  • 8.3. Increased Scrutiny over Spinal Fusion's Necessity in the US
  • 8.4. Restricted Reimbursement from Private Payers
  • 8.5. Performance in Treating Axial Back Pain

9. Pipeline Assessment

10. Clinical Trial Analysis

11. Current and Future Players

  • 11.1. Overview
  • 11.2. Trends in Corporate Strategy
  • 11.3. Company Profiles
    • 11.3.1. Aesculap
    • 11.3.2. Alphatec Spine
    • 11.3.3. Amedica Corporation
    • 11.3.4. Medtronic Spinal and Biologics
    • 11.3.5. DePuy Spine
    • 11.3.6. Globus Medical
    • 11.3.7. K2M
    • 11.3.8. Biomet
    • 11.3.9. Stryker
    • 11.3.10. Zimmer
    • 11.3.11. Nuvasive
    • 11.3.12. Orthofix
    • 11.3.13. Integra LifeSciences

12. Market Outlook

  • 12.1. Company Market Share
    • 12.1.1. US
    • 12.1.2. 5EU
    • 12.1.3. APAC
    • 12.1.4. South America
  • 12.2. By Segment
    • 12.2.1. Spinal Plating Systems
    • 12.2.2. Interbody Cages
    • 12.2.3. Pedicle Screw Systems
  • 12.3. By Geography
    • 12.3.1. Global
    • 12.3.2. US
    • 12.3.3. France
    • 12.3.4. Germany
    • 12.3.5. Italy
    • 12.3.6. Spain
    • 12.3.7. UK
    • 12.3.8. Japan
    • 12.3.9. Brazil
    • 12.3.10. China
    • 12.3.11. India

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Report Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Primary Research
    • 13.3.4. Secondary Research
    • 13.3.5. Forecasting Methodology
  • 13.4. Key Opinion Leaders Included in this Study
  • 13.5. About the Authors
    • 13.5.1. Joseph A. Gregory, Analyst, Surgical Devices
    • 13.5.2. Derek Archila, MBA, Director of Research and Analysis, Medical Devices
  • 13.6. Global Head of Healthcare
    • 13.6.1. Bonnie Bain, Ph.D., Global Head of Healthcare
  • 13.7. About MediPoint
  • 13.8. About GlobalData
  • 13.9. Disclaimer

List of Tables

  • Table 1: Indications for Lumbar Spinal Fusion
  • Table 2: Adoption of Spinal Fusion and Spinal Non-Fusion, US, 2013 and 2020
  • Table 3: Adoption of Spinal Fusion and Spinal Non-Fusion, 5EU, 2013 and 2020
  • Table 4: Spinal Plating Systems CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes
  • Table 5: Interbody Cages CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes
  • Table 6: Pedicle Screw Systems CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes
  • Table 7: Adoption of Spinal Fusion and Spinal Non-Fusion, Brazil, 2013 and 2020
  • Table 8: Adoption of Spinal Fusion and Spinal Non-Fusion, APAC, 2013 and 2020
  • Table 9: Spinal Plating Systems CAGR, APAC, Based on 2013 and 2020 Procedure Volumes
  • Table 10: Interbody Cages CAGR, APAC, Based on 2013 and 2020 Procedure Volumes
  • Table 11: Pedicle Screw Systems CAGR, APAC, Based on 2013 and 2020 Procedure Volumes
  • Table 12: Adoption of Spinal Implants for Cervical Fusion Procedures, 5EU, 2013
  • Table 13: Adoption of Spinal Implants for Thoracolumbar Fusion Procedures, 5EU, 2013
  • Table 14: Adoption of Spinal Implants for Cervical Fusion Procedures, APAC, 2013
  • Table 15: Adoption of Spinal Implants for Thoracolumbar Fusion Procedures, APAC, 2013
  • Table 16: Mergers & Acquisitions, 2010-2014
  • Table 17: Population Aged 60 Years Old or Over, 1950-2050 (in millions) (percentage in older ages)
  • Table 18: Overall Perceived Advantages of Minimally Invasive Surgery Techniques, 2007
  • Table 19: Overall Perceived Limitations of Minimally Invasive Surgery Techniques, 2007
  • Table 20: Company Portfolio - Aesculap
  • Table 21: Product Portfolio - Aesculap
  • Table 22: Company Portfolio - Alphatec Spine
  • Table 23: Product Portfolio - Alphatec Spine
  • Table 24: Company Portfolio - Amedica
  • Table 25: Product Portfolio - Amedica
  • Table 26: Company Portfolio - Medtronic Spinal and Biologics
  • Table 27: Product Portfolio - Medtronic Spinal and Biologics
  • Table 28: Company Portfolio - DePuy Spine
  • Table 29: Product Portfolio - DePuy Spine
  • Table 30: Company Portfolio - Globus Medical
  • Table 31: Product Portfolio - Globus Medical
  • Table 32: Company Portfolio - K2M
  • Table 33: Product Portfolio - K2M
  • Table 34: Company Portfolio - Biomet
  • Table 35: Product Portfolio - Biomet
  • Table 36: Company Portfolio - Stryker
  • Table 37: Product Portfolio - Stryker
  • Table 38: Company Portfolio - Zimmer
  • Table 39: Product Portfolio - Zimmer
  • Table 40: Company Portfolio - Nuvasive
  • Table 41: Product Portfolio - Nuvasive
  • Table 42: Company Portfolio - Orthofix
  • Table 43: Product Portfolio - Orthofix
  • Table 44: Company Portfolio - Integra LifeSciences
  • Table 45: Product Portfolio - Integra LifeSciences
  • Table 46: Spinal Surgery, US Company Market Share, 2012
  • Table 47: Spinal Surgery, 5EU Company Market Share, 2012
  • Table 48: Spinal Surgery, APAC Company Market Share, 2012
  • Table 49: Spinal Surgery, South American Company Market Share, 2012
  • Table 50: Global Spinal Plating Systems Sales ($m) Forecast, 2011-2020
  • Table 51: Global Interbody Cages Sales ($m) Forecast, 2011-2020
  • Table 52: Global Pedicle Screw Systems Sales ($m) Forecast, 2011-2020
  • Table 53: Global Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 54: US Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 55: France Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 56: Germany Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 57: Italy Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 58: Spain Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 59: UK Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 60: Japan Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 61: Brazil Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 62: China Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Table 63: India Spinal Fusion Sales ($m) Forecast, 2011-2020

List of Figures

  • Figure 1: Spinal Fusion Procedure Volumes, US, 2011-2020
  • Figure 2: Spinal Plating Procedure Volumes, 5EU, 2011-2020
  • Figure 3: Interbody Cages Procedure Volumes, 5EU, 2011-2020
  • Figure 4: Pedicle Screw Systems Procedure Volumes, 5EU, 2011-2020
  • Figure 5: Spinal Fusion Procedure Volumes, Brazil, 2011-2020
  • Figure 6: Spinal Plating Procedure Volumes, APAC, 2011-2020
  • Figure 7: Interbody Cages Procedure Volumes, APAC, 2011-2020
  • Figure 8: Pedicle Screw Systems Procedure Volumes, APAC, 2011-2020
  • Figure 9: Adoption of Spinal Implants for the Fusion Procedures, US, 2013
  • Figure 10: Adoption of Spinal Implants for the Fusion Procedures, South America, 2013
  • Figure 11: Spinal Fusion Procedure Volumes, US, 2002-2011
  • Figure 12: Spinal Surgery, US Company Market Share, 2012
  • Figure 13: Spinal Surgery, 5EU Company Market Share, 2012
  • Figure 14: Spinal Surgery, APAC Company Market Share, 2012
  • Figure 15: Spinal Surgery, South American Company Market Share, 2012
  • Figure 16: Global Spinal Plating Systems Sales ($m) Forecast, 2011-2020
  • Figure 17: Global Interbody Cages Sales ($m) Forecast, 2011-2020
  • Figure 18: Global Pedicle Screw Systems Sales ($m) Forecast, 2011-2020
  • Figure 19: Global Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 20: US Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 21: France Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 22: Germany Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 23: Italy Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 24: Spain Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 25: UK Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 26: Japan Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 27: Brazil Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 28: China Spinal Fusion Sales ($m) Forecast, 2011-2020
  • Figure 29: India Spinal Fusion Sales ($m) Forecast, 2011-2020
Back to Top